Amarin’s John Thero Awarded EY Entrepreneur of The Year® 2019 Life Sciences National Award

    NEXT STORY
    Ascendis Pharma A/S Reports Third Quarter 2019 Financial Results
    PREV STORY
    CRISPR Gene Editing Eliminates Herpes Simplex Virus and JC Virus, Demonstrating Feasibility of a Potential Functional Cure
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Adaptimmune Provides Update on Study of NY-ESO SPEAR® T-cell Therapy in Synovial Sarcoma at the European Society for Medical Oncology (ESMO) 2016 Congress

    PHILADELPHIA and OXFORD, United Kingdom, Oct. 09, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc ...

    author_avatar
    NASDAQ Market News

    Innate Pharma to present IPH4102 “TELLOMAK” clinical trial design and preclinical PTCL data at the 2019 ICML

    author_avatar
    NASDAQ Market News

    Pharmacodynamics Evaluation of PhaseBio’s Novel Ticagrelor Reversal Agent Presented at ESC Congress 2019

    author_avatar
    NASDAQ Market News